Device-based therapies for arterial hypertension

L Lauder, M Azizi, AJ Kirtane, M Boehm… - Nature Reviews …, 2020 - nature.com
Arterial hypertension is the most prevalent modifiable risk factor associated with
cardiovascular morbidity and mortality. Although antihypertensive drugs are widely …

Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension

G Mancia, FP Cappuccio, M Burnier… - Journal of Internal …, 2023 - Wiley Online Library
The clinical and economic burden of hypertension is high and continues to increase
globally. Uncontrolled hypertension has severe but avoidable long‐term consequences …

Impact of therapeutic lifestyle changes in resistant hypertension

C Ozemek, S Tiwari, A Sabbahi, S Carbone… - Progress in …, 2020 - Elsevier
Hypertensive individuals are at an increased risk of developing heart disease and stroke.
Adopting healthy lifestyles, such as being active on≥ 4 days per week, weight-loss in the …

Italian Society of Arterial Hypertension (SIIA) position paper on the role of renal denervation in the management of the difficult-to-treat hypertensive patient

RM Bruno, S Taddei, C Borghi, F Colivicchi… - High Blood Pressure & …, 2020 - Springer
Renal denervation is a device-based procedure for hypertension for which safety and
efficacy has been demonstrated. At present, its clinical use is still matter of debate, despite …

Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical …

ASP Sharp, KN Cao, MD Esler… - … Journal-Quality of …, 2024 - academic.oup.com
Aims Catheter-based radiofrequency renal denervation (RF RDN) has recently been
approved for clinical use in the European Society of Hypertension guidelines and by the US …

Controversies in the management of patients with arterial hypertension

M Burnier - Polish Heart Journal (Kardiologia Polska), 2019 - journals.viamedica.pl
Every 5 to 6 years, international and national guidelines provide updated recommendations
for the standard management of hypertension in adults. Thus, within the last 18 months …

Device-based sympathetic nerve regulation for cardiovascular diseases

L Li, Z Hu, Y Xiong, Y Yao - Frontiers in Cardiovascular Medicine, 2021 - frontiersin.org
Sympathetic overactivation plays an important role in promoting a variety of
pathophysiological processes in cardiovascular diseases (CVDs), including ventricular …

Systematic review of renal denervation for the management of cardiac arrhythmias

N Nantha Kumar, K Nyatsuro, S Ahmad… - Clinical Research in …, 2022 - Springer
Background In the wake of the controversy surrounding the SYMPLICITY HTN-3 trial and
data from subsequent trials, this review aims to perform an updated and more …

Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement

L Faconti, J George, S Partridge, C Maniero… - Journal of Human …, 2024 - nature.com
People living with resistant hypertension (RH) are at high risk of adverse cardiovascular
events. The British and Irish Hypertension Society has identified suspected RH as a …

Intravascular renal denervation reduces ambulatory and office blood pressure in patients with essential hypertension: a meta-analysis of randomized sham-controlled …

X Yang, H Liu, S Chen, P Dong, D Zhao - Kidney and Blood Pressure …, 2022 - karger.com
Background: This meta-analysis was designed to evaluate the antihypertensive efficacy of
intravascular renal denervation (RDN) in patients with essential hypertension, especially to …